BACKGROUND/AIMS: We designed this study to examine subsyndromes in Korean patients with Alzheimer's disease (AD) using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). METHODS:Initial participants were 778 AD patients recruited from the Clinical Research Center for Dementia of South Korea and assessed via the Korean Neuropsychiatric Inventory. Those with > or =1 neuropsychiatric symptom were randomly divided into groups. Principal axis factoring with oblimin rotation was used to analyze group 1 inventory results, and maximum likelihood estimation extraction with Bollen-Stine bootstrapping was used for group 2. RESULTS: The results of the EFA showed the presence of 4 subsyndromes: hyperactivity, affect, psychosis and apathy/vegetative symptom. The CFA results indicated this model was the best-fitting model for explaining these subsyndromes. CONCLUSION: Our model showed the best fit and identified 4 subsyndromes. This study might contribute to a clearer understanding of the neuropsychiatric symptoms in AD. 2010 S. Karger AG, Basel.
RCT Entities:
BACKGROUND/AIMS: We designed this study to examine subsyndromes in Korean patients with Alzheimer's disease (AD) using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). METHODS: Initial participants were 778 ADpatients recruited from the Clinical Research Center for Dementia of South Korea and assessed via the Korean Neuropsychiatric Inventory. Those with > or =1 neuropsychiatric symptom were randomly divided into groups. Principal axis factoring with oblimin rotation was used to analyze group 1 inventory results, and maximum likelihood estimation extraction with Bollen-Stine bootstrapping was used for group 2. RESULTS: The results of the EFA showed the presence of 4 subsyndromes: hyperactivity, affect, psychosis and apathy/vegetative symptom. The CFA results indicated this model was the best-fitting model for explaining these subsyndromes. CONCLUSION: Our model showed the best fit and identified 4 subsyndromes. This study might contribute to a clearer understanding of the neuropsychiatric symptoms in AD. 2010 S. Karger AG, Basel.
Authors: Corinne E Fischer; Winnie Qian; Tom A Schweizer; Colleen P Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; Paul Shelton; David G Munoz Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Brendan J Guercio; Nancy J Donovan; Catherine E Munro; Sarah L Aghjayan; Sarah E Wigman; Joseph J Locascio; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Kerry L Ivey; Xuan-Mai T Nguyen; Daniel Posner; Geraint B Rogers; Deirdre K Tobias; Rebecca Song; Yuk-Lam Ho; Ruifeng Li; Peter W F Wilson; Kelly Cho; John Michael Gaziano; Frank B Hu; Walter C Willett; Luc Djoussé Journal: Nutrients Date: 2021-04-19 Impact factor: 6.706
Authors: Victoria García-Martín; M Canto de Hoyos-Alonso; Gloria Ariza-Cardiel; Rosalía Delgado-Puebla; Paula García-Domingo; Erika Hernández-Melo; Javier López de Haro-de Torres; Isabel Del Cura-González Journal: BMC Geriatr Date: 2022-01-22 Impact factor: 3.921